IT Solutions
Data Integrity module
Feb 21 2018
LabWare has developed and launched a new data integrity module for its enterprise LIMS and ELN solution to help drug manufacturers conform to the FDA draft guidance on ‘Data Integrity and Compliance with CGMP’.
The new enhancement to LabWare LIMS & ELN ensures that companies are able to meet current and proposed regulatory guidance regarding the management of data in temporary memory. New and emerging data integrity standards put forth by the U.S. Food and Drug Administration (FDA), U.K. Medicines and Healthcare Products Regulatory Agency (MHRA), and World Health Organization (WHO), which would require the capture of temporary data in electronic records.
The new features are in addition to LabWare current solution that supports a GxP-compliant audit trail based on a full history of analytical testing, including:
Forced Save during manual result entry, to mitigate manipulation of values in temporary memory.
Disabling manual entry when data is captured directly from instrumentation
Forced reviews of Audit Trail entries when exceptions occur, such as result modification
Checksum generation and checking against data records, to detect manipulation.
Date time of data entry
Electronic Signature and mandatory reason for change
Digital Edition
International Labmate 49.6 - Sept 2024
September 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan